VistaGen Therapeutics, Inc.
VTGN
$3.16
$0.10443.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.71% | 3.22% | -8.70% | -20.76% | -12.73% |
| Total Depreciation and Amortization | 1.81% | 3.11% | 2.55% | 3.97% | 2.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.91% | -14.62% | 0.62% | -14.81% | 116.10% |
| Change in Net Operating Assets | -283.28% | -3.67% | 182.24% | 166.25% | -176.73% |
| Cash from Operations | -87.30% | 2.12% | 5.57% | -0.16% | -55.60% |
| Capital Expenditure | 26.14% | -- | 100.00% | -45.24% | -44.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -217.56% | 245.73% | 94.54% | -42.40% | -- |
| Cash from Investing | -249.53% | 224.88% | 94.58% | -42.42% | -18,751.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -71.40% | 66.61% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.73% | 66.61% | -- | -100.00% | 123.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.27% | 20.43% | 48.96% | -14.92% | -119.75% |